{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-000980","form_type":"8-K","ticker":"JSPR","cik":"0001788028","company_name":"Jasper Therapeutics, Inc.","filed_at":"2024-01-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.539309+00:00","generated_at":"2026-06-07T04:09:04.615004+00:00","sec_items":["3.03","5.03","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Jasper Therapeutics effects 1-for-10 reverse stock split to regain Nasdaq compliance","bullets":["Reverse split effective 12:01 a.m. ET on Jan 4, 2024; shares begin trading split-adjusted same day.","Common stock CUSIP changed to 471871202; trading symbol remains JSPR.","Warrants (JSPRW) adjusted: 10 pre-split warrants exercisable for 1 share at $115.00 exercise price.","No fractional shares issued; cash in lieu paid based on Jan 3, 2024 closing price.","Split approved by board on Dec 22, 2023, after stockholder authorization on Dec 15, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-000980","json":"https://secwatch.observer/filing/0001213900-24-000980.json","markdown":"https://secwatch.observer/filing/0001213900-24-000980.md","text":"https://secwatch.observer/filing/0001213900-24-000980.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1788028/000121390024000980/0001213900-24-000980-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1788028/000121390024000980/ea191024-8k_jasper.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T04:09:04.615004+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"88398088897e26a118e311ad7011ae9eecfdb034","claim":"Jasper Therapeutics, Inc.: Effected a 1-for-10 reverse stock split to regain compliance with Nasdaq minimum bid price requirement (effective 2024-01-04).","evidence_excerpt":"The Reverse Stock Split was effective at 12:01 a.m., Eastern Time, on January 4, 2024, and the Common Stock is expected to begin trading on a Reverse Stock Split-adjusted basis on the Nasdaq Capital Market at the opening of the market on January 4, 2024.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1788028/000121390024000980/0001213900-24-000980-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2024-01-04"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}